Published in Infect Immun on January 31, 2011
Intestinal CD103+ dendritic cells are key players in the innate immune control of Cryptosporidium parvum infection in neonatal mice. PLoS Pathog (2013) 0.87
Systemic and Mucosal Immune Responses to Cryptosporidium-Vaccine Development. Curr Trop Med Rep (2015) 0.77
Non-coding RNAs in epithelial immunity to Cryptosporidium infection. Parasitology (2014) 0.77
Bovine cryptosporidiosis: impact, host-parasite interaction and control strategies. Vet Res (2017) 0.75
Cryptosporidium spp. and cryptosporidiosis. Microbiol Rev (1986) 5.54
Neonatal adaptive immunity comes of age. Nat Rev Immunol (2004) 5.31
Cryptosporidiosis. N Engl J Med (2002) 3.24
Persistent Cryptosporidium infection in congenitally athymic (nude) mice. Infect Immun (1984) 2.53
Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists. Blood (2008) 1.94
Cryptosporidium infection in an adult mouse model. Independent roles for IFN-gamma and CD4+ T lymphocytes in protective immunity. J Immunol (1991) 1.87
New mouse models for chronic Cryptosporidium infection in immunodeficient hosts. Infect Immun (1990) 1.71
IL-4 utilizes an alternative receptor to drive apoptosis of Th1 cells and skews neonatal immunity toward Th2. Immunity (2004) 1.61
Delayed maturation of an IL-12-producing dendritic cell subset explains the early Th2 bias in neonatal immunity. J Exp Med (2008) 1.46
Hyper innate responses in neonates lead to increased morbidity and mortality after infection. Proc Natl Acad Sci U S A (2008) 1.33
Susceptibility of major histocompatibility complex (MHC) class I- and MHC class II-deficient mice to Cryptosporidium parvum infection. Infect Immun (1994) 1.27
IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum. J Immunol (1996) 1.23
Cryptosporidiosis. BMJ (2009) 1.15
Cryptosporidium parvum infection in T-cell receptor (TCR)-alpha- and TCR-delta-deficient mice. Infect Immun (1996) 1.14
Mechanisms of innate and acquired resistance to Cryptosporidium parvum infection in SCID mice. Parasite Immunol (1994) 1.13
"Default" generation of neonatal regulatory T cells. J Immunol (2010) 1.10
MyD88-dependent pathways mediate resistance to Cryptosporidium parvum infection in mice. Infect Immun (2006) 1.04
Oral and intraperitoneal administration of phosphorothioate oligodeoxynucleotides leads to control of Cryptosporidium parvum infection in neonatal mice. J Infect Dis (2006) 1.03
Interferon-gamma expression in jejunal biopsies in experimental human cryptosporidiosis correlates with prior sensitization and control of oocyst excretion. J Infect Dis (2000) 1.03
Inchoate CD8+ T cell responses in neonatal mice permit influenza-induced persistent pulmonary dysfunction. J Immunol (2008) 1.02
Cryptosporidium parvum infection in bovine neonates: dynamic clinical, parasitic and immunologic patterns. Int J Parasitol (1998) 1.01
Interleukin-15 activates human natural killer cells to clear the intestinal protozoan cryptosporidium. J Infect Dis (2005) 0.99
Neonatal B cells suppress innate toll-like receptor immune responses and modulate alloimmunity. J Immunol (2007) 0.99
Susceptibility differences to Cryptosporidium parvum infection in two strains of gamma interferon knockout mice. J Parasitol (1998) 0.97
Interferon-gamma is required for innate immunity to Cryptosporidium parvum in mice. J Infect Dis (2000) 0.97
An early intestinal mucosal source of gamma interferon is associated with resistance to and control of Cryptosporidium parvum infection in mice. Infect Immun (2005) 0.97
Neonatal goats display a stronger TH1-type cytokine response to TLR ligands than adults. Dev Comp Immunol (2008) 0.95
Rapid increase of mucosal CD4 T cells followed by clearance of intestinal cryptosporidiosis in an AIDS patient receiving highly active antiretroviral therapy. Gastroenterology (2001) 0.94
Human CD8(+) T cells clear Cryptosporidium parvum from infected intestinal epithelial cells. Am J Trop Med Hyg (2010) 0.92
The neonatal development of intraepithelial and lamina propria lymphocytes in the murine small intestine. Dev Immunol (1997) 0.91
In vitro proliferation and production of gamma interferon by murine CD4+ cells in response to Cryptosporidium parvum antigen. J Parasitol (1994) 0.88
Cytokine profile induced by Cryptosporidium antigen in peripheral blood mononuclear cells from immunocompetent and immunosuppressed persons with cryptosporidiosis. J Infect Dis (1999) 0.88
Roles for NK cells and an NK cell-independent source of intestinal gamma interferon for innate immunity to Cryptosporidium parvum infection. Infect Immun (2009) 0.87
Development of cellular immune functions in neonatal to weanling mice: relationship to Cryptosporidium parvum infection. J Parasitol (1996) 0.86
Susceptibility to Cryptosporidium parvum infections in cytokine- and chemokine-receptor knockout mice. J Parasitol (2002) 0.86
Evidence for the emergence of a type-1-like immune response in intestinal mucosa of calves recovering from cryptosporidiosis. J Parasitol (2001) 0.82
Kinetics of spleen and Peyer's patch lymphocyte populations during gut parasite clearing in Cryptosporidium parvum infected suckling mice. Parasite Immunol (2004) 0.80
Liver invariant NKT cells and listeriosis. Microbes Infect (2008) 0.78
Increased susceptibility of beta7-integrin-deficient neonatal mice in the early stage of Cryptosporidium parvum infection. Infect Immun (2004) 0.77
Innate lymphoid cells--a proposal for uniform nomenclature. Nat Rev Immunol (2013) 7.94
Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity (2008) 6.49
The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat Immunol (2010) 6.02
Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells. Nature (2011) 4.92
Lineage relationship analysis of RORgammat+ innate lymphoid cells. Science (2010) 4.12
In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORgamma t+ T cells. J Exp Med (2008) 3.85
A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127. Nat Immunol (2006) 3.74
IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J Exp Med (2008) 3.03
RORγt+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota. Nat Immunol (2011) 3.03
IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors. J Exp Med (2010) 2.87
Developmental pathways that generate natural-killer-cell diversity in mice and humans. Nat Rev Immunol (2007) 2.66
Humanized mice for modeling human infectious disease: challenges, progress, and outlook. Cell Host Microbe (2009) 2.58
Roles for common cytokine receptor gamma-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo. J Immunol (2005) 2.35
What does it take to make a natural killer? Nat Rev Immunol (2003) 2.30
Thymic stromal-derived lymphopoietin distinguishes fetal from adult B cell development. Nat Immunol (2003) 2.24
IL-15 is an essential mediator of peripheral NK-cell homeostasis. Blood (2003) 2.20
GATA-3 promotes maturation, IFN-gamma production, and liver-specific homing of NK cells. Immunity (2003) 2.15
Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases. Nat Immunol (2006) 2.15
Debugging how bacteria manipulate the immune response. Immunity (2007) 2.06
The thymus exports long-lived fully committed T cell precursors that can colonize primary lymphoid organs. Nat Immunol (2005) 1.98
Cellular senescence in human myoblasts is overcome by human telomerase reverse transcriptase and cyclin-dependent kinase 4: consequences in aging muscle and therapeutic strategies for muscular dystrophies. Aging Cell (2007) 1.98
NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases. Nat Immunol (2003) 1.89
Regulation of cytokine secretion in human CD127(+) LTi-like innate lymphoid cells by Toll-like receptor 2. Immunity (2010) 1.85
CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells. J Exp Med (2007) 1.82
IL-1β regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function. Eur J Immunol (2010) 1.79
Neutrophils mediate antibody-induced antitumor effects in mice. Blood (2013) 1.66
gamma(c) cytokines provide multiple homeostatic signals to naive CD4(+) T cells. Eur J Immunol (2007) 1.55
Renaissance for mouse models of human hematopoiesis and immunobiology. Nat Immunol (2009) 1.54
IL-15 availability conditions homeostasis of peripheral natural killer T cells. Proc Natl Acad Sci U S A (2003) 1.45
The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium. J Immunol (2009) 1.44
Natural killer cell activation in mice and men: different triggers for similar weapons? Nat Immunol (2002) 1.44
Gata3 drives development of RORγt+ group 3 innate lymphoid cells. J Exp Med (2014) 1.36
Functional CD47/signal regulatory protein alpha (SIRP(alpha)) interaction is required for optimal human T- and natural killer- (NK) cell homeostasis in vivo. Proc Natl Acad Sci U S A (2011) 1.35
An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation. J Immunol (2008) 1.34
Are major histocompatibility complex molecules involved in the survival of naive CD4+ T cells? J Exp Med (2003) 1.34
Essential, dose-dependent role for the transcription factor Gata3 in the development of IL-5+ and IL-13+ type 2 innate lymphoid cells. Proc Natl Acad Sci U S A (2013) 1.34
Intravital imaging reveals distinct dynamics for natural killer and CD8(+) T cells during tumor regression. Immunity (2010) 1.32
Distinguishing features of developing natural killer cells. Curr Opin Immunol (2005) 1.31
Generation of human antigen-specific monoclonal IgM antibodies using vaccinated "human immune system" mice. PLoS One (2010) 1.29
Natural cytotoxicity uncoupled from the Syk and ZAP-70 intracellular kinases. Nat Immunol (2002) 1.29
Characterization of the thymic IL-7 niche in vivo. Proc Natl Acad Sci U S A (2009) 1.27
Interplay between alpha/beta and gamma interferons with B, T, and natural killer cells in the defense against herpes simplex virus type 1. J Virol (2004) 1.24
Th17 cells are the dominant T cell subtype primed by Shigella flexneri mediating protective immunity. J Immunol (2010) 1.22
IL-7 enhances thymic human T cell development in "human immune system" Rag2-/-IL-2Rgammac-/- mice without affecting peripheral T cell homeostasis. J Immunol (2009) 1.18
Repopulation efficiencies of adult hepatocytes, fetal liver progenitor cells, and embryonic stem cell-derived hepatic cells in albumin-promoter-enhancer urokinase-type plasminogen activator mice. Am J Pathol (2009) 1.18
Roles for T and NK cells in the innate immune response to Shigella flexneri. J Immunol (2005) 1.17
Role of an intact splenic microarchitecture in early lymphocytic choriomeningitis virus production. J Virol (2002) 1.14
IL-2 is required for the activation of memory CD8+ T cells via antigen cross-presentation. J Immunol (2006) 1.13
Interleukin-15-dependent NKp46+ innate lymphoid cells control intestinal inflammation by recruiting inflammatory monocytes. Immunity (2012) 1.12
Thymocytes may persist and differentiate without any input from bone marrow progenitors. J Exp Med (2012) 1.12
Pre-B cell receptor expression is necessary for thymic stromal lymphopoietin responsiveness in the bone marrow but not in the liver environment. Proc Natl Acad Sci U S A (2004) 1.11
Enhancement of myogenic and muscle repair capacities of human adipose-derived stem cells with forced expression of MyoD. Mol Ther (2009) 1.11
IL-15 transpresentation promotes both human T-cell reconstitution and T-cell-dependent antibody responses in vivo. Proc Natl Acad Sci U S A (2011) 1.10
Myogenic cell proliferation and generation of a reversible tumorigenic phenotype are triggered by preirradiation of the recipient site. J Cell Biol (2002) 1.10
Identification of the earliest prethymic bipotent T/NK progenitor in murine fetal liver. Blood (2002) 1.09
Invariant V alpha 14+ NKT cells participate in the early response to enteric Listeria monocytogenes infection. J Immunol (2005) 1.08
GATA-3 promotes T-cell specification by repressing B-cell potential in pro-T cells in mice. Blood (2013) 1.08
Differential regulation of beta-defensin gene expression during Cryptosporidium parvum infection. Infect Immun (2004) 1.07
Competition within the early B-cell compartment conditions B-cell reconstitution after hematopoietic stem cell transplantation in nonirradiated recipients. Blood (2006) 1.06
Isolation of a highly myogenic CD34-negative subset of human skeletal muscle cells free of adipogenic potential. Stem Cells (2010) 1.06
Dynamic behavior of NK cells during activation in lymph nodes. Blood (2009) 1.04
Repopulation of athymic mouse liver by cryopreserved early human fetal hepatoblasts. Hum Gene Ther (2004) 1.03
Proinflammatory macrophages enhance the regenerative capacity of human myoblasts by modifying their kinetics of proliferation and differentiation. Mol Ther (2012) 1.01
c-Jun NH2-terminal kinase/c-Jun signaling promotes survival and metastasis of B lymphocytes transformed by Theileria. Cancer Res (2006) 1.01
Cutting edge: Thymic NK cells develop independently from T cell precursors. J Immunol (2010) 1.01
NK cell responses to Plasmodium infection and control of intrahepatic parasite development. J Immunol (2006) 1.00
Developmental programming of natural killer and innate lymphoid cells. Curr Opin Immunol (2013) 0.98
Lymphocytes support oval cell-dependent liver regeneration. J Immunol (2008) 0.98
Origin, trafficking, and intraepithelial fate of gut-tropic T cells. J Exp Med (2013) 0.95
Gamma(c) deficiency precludes CD8+ T cell memory despite formation of potent T cell effectors. Proc Natl Acad Sci U S A (2010) 0.95
IkappaBalpha/IkappaBepsilon deficiency reveals that a critical NF-kappaB dosage is required for lymphocyte survival. Proc Natl Acad Sci U S A (2003) 0.95
Thymocyte selection regulates the homeostasis of IL-7-expressing thymic cortical epithelial cells in vivo. J Immunol (2013) 0.95
Comparative analysis of genetically engineered immunodeficient mouse strains as recipients for human myoblast transplantation. Cell Transplant (2005) 0.94
Cutting Edge: A dual role for type I IFNs during polyinosinic-polycytidylic acid-induced NK cell activation. J Immunol (2011) 0.94
Interleukin-4 and transforming growth factor beta have opposing regulatory effects on gamma interferon-mediated inhibition of Cryptosporidium parvum reproduction. Infect Immun (2003) 0.93
The intrathymic crossroads of T and NK cell differentiation. Immunol Rev (2010) 0.93
Human myoblast engraftment is improved in laminin-enriched microenvironment. Transplantation (2008) 0.92
NK cells and polymorphonuclear neutrophils are both critical for IL-2-induced pulmonary vascular leak syndrome. J Immunol (2004) 0.90
Cutting Edge: a thymocyte-thymic epithelial cell cross-talk dynamically regulates intrathymic IL-7 expression in vivo. J Immunol (2010) 0.90
Protection against the early acute phase of Cryptosporidium parvum infection conferred by interleukin-4-induced expression of T helper 1 cytokines. J Infect Dis (2004) 0.90
Lymphotoxin-β receptor-independent development of intestinal IL-22-producing NKp46+ innate lymphoid cells. Eur J Immunol (2011) 0.89
Multiple survival signals are delivered by dendritic cells to naive CD4+ T cells. Eur J Immunol (2005) 0.88
Slowing down differentiation of engrafted human myoblasts into immunodeficient mice correlates with increased proliferation and migration. Mol Ther (2011) 0.87
Roles for NK cells and an NK cell-independent source of intestinal gamma interferon for innate immunity to Cryptosporidium parvum infection. Infect Immun (2009) 0.87
Combined deficiency in IkappaBalpha and IkappaBepsilon reveals a critical window of NF-kappaB activity in natural killer cell differentiation. Blood (2004) 0.85
A protective role for interleukin 18 in interferon γ-mediated innate immunity to Cryptosporidium parvum that is independent of natural killer cells. J Infect Dis (2012) 0.84
IL-22 is produced by γC-independent CD25+ CCR6+ innate murine spleen cells upon inflammatory stimuli and contributes to LPS-induced lethality. Eur J Immunol (2011) 0.84
Thymic epithelial cells: the multi-tasking framework of the T cell "cradle". Trends Immunol (2009) 0.84
The Rag2⁻Il2rb⁻Dmd⁻ mouse: a novel dystrophic and immunodeficient model to assess innovating therapeutic strategies for muscular dystrophies. Mol Ther (2013) 0.84
A new heterogeneous family of telomerically encoded Cryptosporidium proteins. Evol Appl (2012) 0.84
Role of tumor necrosis factor alpha in development of immunity against Cryptosporidium parvum infection. Infect Immun (2006) 0.84
Gamma c cytokines condition the progressive differentiation of CD4+ T cells. Proc Natl Acad Sci U S A (2007) 0.84
Epitope specificity and relative clonal abundance do not affect CD8 differentiation patterns during lymphocytic choriomeningitis virus infection. J Virol (2009) 0.83
Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim sustains B lymphopoiesis in the absence of IL-7. Int Immunol (2009) 0.83
The role of cytokines in the pathogenesis of Cryptosporidium infection. Curr Opin Infect Dis (2002) 0.83
Cryptosporidium parvum infection rapidly induces a protective innate immune response involving type I interferon. J Infect Dis (2009) 0.83
Interleukin signaling. Curr Biol (2002) 0.82
Uncoupling protein-3 (UCP3) mRNA expression in reconstituted human muscle after myoblast transplantation in RAG2-/-/gamma c/C5(-) immunodeficient mice. J Biol Chem (2002) 0.82
Interleukin-7, a new cytokine targeting the mouse hypothalamic arcuate nucleus: role in body weight and food intake regulation. PLoS One (2010) 0.82